Severe angioedema requiring airway intervention following evolocumab administration: a case report
{{output}}
Evolocumab is a human monoclonal antibody that effectively reduces low-density lipoprotein (LDL) cholesterol levels by inhibiting proprotein convertase subtilisin-kexin type 9 (PCSK9). Although generally well tolerated, evolocumab may rarely lead to severe hyp... ...
